We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Steven Rowe

Steven P. Rowe MD, PhD

Associate Professor of Radiology, Urology, and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Rowe completed residency training in radiology and nuclear medicine at Johns Hopkins University School of Medicine, subsequently joining the faculty there in 2016. Since that time, he has been engaged in research focused on molecular imaging of genitourinary malignancies. His focus has included prostate-specific membrane antigen (PSMA) positron emission tomography (PET) for prostate cancer and renal cell carcinoma, as well as the use of non-invasive methods to improve risk stratification in patients with indeterminate renal masses. He is currently actively interested in projects at the crossroads of molecular imaging and artificial intelligence.

Disclosures

Dr. Rowe has a consulting agreement with and receives research funding from Lantheus Medical Imaging/Progenics Pharmaceuticals. He has a consulting agreement with, has equity in, and receives research funding from Precision Molecular, Inc. He has equity in and receives research funding from PlenaryAI, Inc.